Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 80

Tests names and labsConditionsGenes and analytesMethods

CentoICU platinum

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

CentoICU platinum plus

Centogene AG - the Rare Disease Company
Germany
769514
  • C Sequence analysis of the entire coding region

RET, selective sequencing of exons 5, 8, 10, 11 and 13-16

Centogene AG - the Rare Disease Company
Germany
61
  • T Targeted variant analysis

Multiple Endocrine Neoplasia Type 2

Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital
United States
41
  • E Sequence analysis of select exons

Multiple endocrine neoplasia type IIB

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Multiple Endoctine Neoplasia Type 2 (RET)

Molecular Genetics Laboratory London Health Sciences Centre
Canada
51
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Multiple Endocrine Neoplasia, Type 2 panel

National Taiwan University Hospital A1 Center National Taiwan University Hospital
Taiwan
41
  • C Sequence analysis of the entire coding region

Hereditary Thyroid Cancer - RET Gene Analysis

GeneKor MSA
Greece
41
  • E Sequence analysis of select exons

RET. Detection of the mutations p.Met918Thr and p.Ala883Phe by sequencing

Instituto de Medicina Genomica
Spain
11
  • T Targeted variant analysis

RET. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

MitoMet®Plus aCGH Analysis

Baylor Miraca Genetics Laboratories
United States
845637
  • D Deletion/duplication analysis

Multiple Endocrine Neoplasia Type 2B (MEN2B) via the RET Gene, Exons 15-16

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Endocrine Cancer: Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
1413
  • D Deletion/duplication analysis

Early Onset Inflammatory Bowel Disease: Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
4926
  • D Deletion/duplication analysis

Congenital Central Hypoventilation Syndrome: Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
117
  • D Deletion/duplication analysis

MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN2)

Laboratorio de Genetica Clinica SL
Spain
21
  • C Sequence analysis of the entire coding region

Multiple Endocrine Neoplasia type 2B (sequence analysis of RET gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Multiple Endocrine Neoplasia type 2B (sequence analysis of RET gene)

CGC Genetics
Portugal
11
  • C Sequence analysis of the entire coding region

Multiple Endocrine Neoplasia Type 2, Deletions-Duplications (MLPA) RET Gene

Reference Laboratory Genetics
Spain
21
  • D Deletion/duplication analysis

Multiple Endocrine Neoplasia Type 2B, Sequencing Exons (15,16) RET Gene

Reference Laboratory Genetics
Spain
11
  • E Sequence analysis of select exons

Results: 1 to 20 of 80

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center